Story perspectives

Alito Pauses 5th Circuit Mifepristone Restriction, Stay Ends May 11

5/8/2026

50 9

Summary

Story summary

Justice Samuel Alito temporarily halted the 5th Circuit’s restriction on mail-order and telemedicine mifepristone.
Danco Laboratories and GenBioPro filed emergency appeals to block the appellate decision.
Louisiana urged the Court to keep the restriction, saying it undermines the state’s abortion ban and Medicaid costs.
Planned Parenthood welcomed the stay but warned that the ongoing legal fight creates confusion, noting the stay expires at 5 p.m. EDT on May 11.

History

Historical Context

After European approvals in the late 1980s and early 1990s, the U.S. granted conditional use of mifepristone in 1996 and full FDA approval in 2000, following Clinton-era pressure and the Population Council’s licensing to Danco Laboratories. Decades later, Justice Samuel Alito’s temporary stay of a Fifth Circuit restriction revives the same legal clash, now involving Danco and generic maker GenBioPro.

1 of 2

Story summary

Justice Samuel Alito temporarily halted the 5th Circuit’s restriction on mail-order and telemedicine mifepristone.
Danco Laboratories and GenBioPro filed emergency appeals to block the appellate decision.
Louisiana urged the Court to keep the restriction, saying it undermines the state’s abortion ban and Medicaid costs.
Planned Parenthood welcomed the stay but warned that the ongoing legal fight creates confusion, noting the stay expires at 5 p.m. EDT on May 11.

1 / 2